These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6976509)

  • 1. Effect of L-5HTP and drugs acting on serotonin metabolism in various myoclonic syndromes.
    Avanzini G; Bossi L; Caraceni T; Consolazione A; Franceschetti S; Negri S; Parati E
    Monogr Neural Sci; 1980; 5():142-52. PubMed ID: 6976509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.
    Chadwick D; Hallett M; Harris R; Jenner P; Reynolds EH; Marsden CD
    Brain; 1977 Sep; 100(3):455-87. PubMed ID: 412560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulation of brain serotonin in the treatment of myoclonus.
    Chadwick D; Jenner P; Harris R; Reynolds EH; Marsden CD
    Lancet; 1975 Sep; 2(7932):434-5. PubMed ID: 51240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetazolamide improves action myoclonus in Ramsay Hunt syndrome.
    Vaamonde J; Legarda I; Jimenez-Jimenez J; Obeso JA
    Clin Neuropharmacol; 1992 Oct; 15(5):392-6. PubMed ID: 1423338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ramsay-Hunt syndrome and aniridia in 2 monozygotic twins].
    Chazot G; Guard O; Setiey A; Robert JM; Schott B
    Rev Neurol (Paris); 1975 Jan; 131(1):43-8. PubMed ID: 1080872
    [No Abstract]   [Full Text] [Related]  

  • 6. Acetazolamide therapy improves action myoclonus in Ramsay Hunt Syndrome.
    Baig SM
    J Neurol Sci; 1997 Jan; 145(1):123-4. PubMed ID: 9073041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent.
    Growdon JH; Young RR; Shahani BT
    Neurology; 1976 Dec; 26(12):1135-40. PubMed ID: 1086988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486.
    Van Woert MH; Sethy VH
    Neurology; 1975 Feb; 25(2):135-40. PubMed ID: 1078720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa.
    Van Woert MH; Rosenbaum D; Howieson J; Bowers MB
    N Engl J Med; 1977 Jan; 296(2):70-5. PubMed ID: 401457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of posthypoxic action myoclonus: implications for the pathophysiology of the disorder.
    Chadwick D; Hallett M; Jenner P; Marsden CD
    Adv Neurol; 1986; 43():183-90. PubMed ID: 2418645
    [No Abstract]   [Full Text] [Related]  

  • 11. Action myoclonus, Ramsay Hunt syndrome, and other cerebellar myoclonic syndromes.
    Lance JW
    Adv Neurol; 1986; 43():33-55. PubMed ID: 3080851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional independence in post-anoxic myoclonus: contribution of L-5-HTP sodium valproate and clonazepam.
    Carroll WM; Walsh PJ
    Br Med J; 1978 Dec; 2(6152):1612. PubMed ID: 365292
    [No Abstract]   [Full Text] [Related]  

  • 13. Beneficial effects of serotonin precursors in postanoxic action myoclonus.
    De Léan J; Richardson JC; Hornykiewicz O
    Neurology; 1976 Sep; 26(9):863-8. PubMed ID: 1084968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin and myoclonus.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Monogr Neural Sci; 1976; 3():71-80. PubMed ID: 790170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimyoclonic properties of S2 serotonin receptor antagonists in the rat.
    Pranzatelli MR; Snodgrass SR
    Neuropharmacology; 1986 Jan; 25(1):5-12. PubMed ID: 2936977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic drugs, benzodiazepines and baclofen block muscimol-induced myoclonic jerks in a strain of mice.
    Menon MK; Vivonia CA
    Eur J Pharmacol; 1981 Jul; 73(2-3):155-61. PubMed ID: 6118280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of clonazepam in myoclonus in relation to effects on GABA and 5-HT.
    Jenner P; Pratt JA; Marsden CD
    Adv Neurol; 1986; 43():629-43. PubMed ID: 2418652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral supersensitivity to 5-hydroxytryptophan induced by chronic methysergide pretreatment.
    Klawans HL; D'Amico DJ; Patel BC
    Psychopharmacologia; 1975 Nov; 44(3):297-300. PubMed ID: 1082146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDT-induced myoclonus: serotonin and alpha noradrenergic interaction.
    Hwang EC; Van Woert MH
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):257-66. PubMed ID: 37558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine in the treatment of intention myoclonus.
    Van Woert MH; Magnussen I; Rosenbaum D; Chung E
    Clin Neuropharmacol; 1983 Mar; 6(1):49-54. PubMed ID: 6189599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.